214 related articles for article (PubMed ID: 23379500)
21. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
22. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) in patients with interstitial pneumonia].
Shiraki A; Ando M; Shindoh J; Abe T; Wakahara K; Makino Y; Asano T; Nakashima H; Hase T; Shigemitsu K; Horiba M; Shimokata K
Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):921-6. PubMed ID: 18186236
[TBL] [Abstract][Full Text] [Related]
24. Optimal Settings for Double Filtration Plasmapheresis With Targeted Removal Rate of Preexisting Antibody in Antibody-Incompatible Kidney Transplant.
Iwami D; Miura M; Chiba Y; Ota M; Matsumoto T; Hotta K; Sasaki H; Hirose T; Harada H; Shinohara N
Transplant Proc; 2018 Dec; 50(10):3478-3482. PubMed ID: 30577224
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of double filtration plasmapheresis in removing xenoantibodies and prolonging xenograft survival in an ex vivo swine perfusion model.
Lee YT; Chu CH; Sue SH; Chen IC; Wei J
Transplant Proc; 2012 May; 44(4):1143-5. PubMed ID: 22564648
[TBL] [Abstract][Full Text] [Related]
26. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
[TBL] [Abstract][Full Text] [Related]
27. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
[TBL] [Abstract][Full Text] [Related]
28. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
[TBL] [Abstract][Full Text] [Related]
29. Juvenile slow progressive antineutrophil cytoplasmic antibody-associated vasculitis diagnosed after kidney transplantation: a case report.
Hasegawa J; Wakai S; Shirakawa H
Ther Apher Dial; 2015 Jun; 19(3):303-4. PubMed ID: 25545671
[No Abstract] [Full Text] [Related]
30. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody.
Yokoseki A; Saji E; Arakawa M; Kosaka T; Hokari M; Toyoshima Y; Okamoto K; Takeda S; Sanpei K; Kikuchi H; Hirohata S; Akazawa K; Kakita A; Takahashi H; Nishizawa M; Kawachi I
Brain; 2014 Feb; 137(Pt 2):520-36. PubMed ID: 24271323
[TBL] [Abstract][Full Text] [Related]
31. A case of Wegener's granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP).
Iwatani H; Uzu T; Kakihara M; Nakayama Y; Kanasaki K; Yamato M; Hirai Y; Umimoto K; Yamauchi A
Clin Exp Nephrol; 2004 Dec; 8(4):369-74. PubMed ID: 15619039
[TBL] [Abstract][Full Text] [Related]
32. [The relationship between subclassification of anti-myeloperoxidase IgG by enzyme-linked immuno-sorbent assay analysis and vasculitis activity].
Yu F; Zhao MH; Zhang YK; Wang HY
Zhonghua Nei Ke Za Zhi; 2003 Jan; 42(1):27-30. PubMed ID: 12757660
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of IgG subclass of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil induced vasculitis].
Gao Y; Zhao MH; Guo XH; Zhang Y; Wang HY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1625-8. PubMed ID: 15569458
[TBL] [Abstract][Full Text] [Related]
34. [Vasculitis and its renal manifestation with special reference to anti-neutrophil cytoplasmic antibody].
Minota S
Rinsho Byori; 2003 Mar; 51(3):231-8. PubMed ID: 12707996
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
Almroth G; Berlin G; Andersson B; Hahn-Zoric M
Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
[TBL] [Abstract][Full Text] [Related]
36. Double filtration plasmapheresis in different diseases in Thailand.
Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
[TBL] [Abstract][Full Text] [Related]
37. Clinical experience of double filtration plasmapheresis for drug refractory neurological diseases.
Ito Y; Odaka M; Tabata Y; Soeda K; Hayashi H; Kobayashi S; Sato T; Yamane S; Isono K
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):27-35. PubMed ID: 1751677
[TBL] [Abstract][Full Text] [Related]
38. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
39. Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels.
Hanafusa N; Satonaka H; Doi K; Noiri E; Fujita T
Ther Apher Dial; 2010 Jun; 14(3):287-91. PubMed ID: 20609180
[TBL] [Abstract][Full Text] [Related]
40. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
Apaydin S
Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]